Views

CrossRef citations to date

Altmetric

Research

Hypnotics use in children 0–18 months: moderate agreement between mother-reported survey data and prescription registry data

Ingvild Holdø1 Norwegian Centre of Addiction Research (SERAF),University of Oslo,Oslo,Norway.

Jørgen G. Bramness2 Norwegian National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders,Ottestad,Norway.

Marte Handal3 Domain of Mental and Physical health,Norwegian Institute of Public Health,Oslo,Norway.

Leila Torgersen3 Domain of Mental and Physical health,Norwegian Institute of Public Health,Oslo,Norway.

Ted Reichborn-Kjennerud3 Domain of Mental and Physical health,Norwegian Institute of Public Health,Oslo,Norway.;4 Institute of Clinical Medicine, University of Oslo,Oslo,Norway.

Eivind Ystrøm3 Domain of Mental and Physical health,Norwegian Institute of Public Health,Oslo,Norway.;5 PharmacoEpidemiology and Drug Safety Research Group,School of Pharmacy, University of Oslo,Oslo,Norway.;6 Section of Health, Developmental and Personality Psychology, Department of Psychology,University of Oslo,Oslo,Norway.

Hedvig Nordeng3 Domain of Mental and Physical health,Norwegian Institute of Public Health,Oslo,Norway.;5 PharmacoEpidemiology and Drug Safety Research Group,School of Pharmacy, University of Oslo,Oslo,Norway.

Svetlana Skurtveit1 Norwegian Centre of Addiction Research (SERAF),University of Oslo,Oslo,Norway.;3 Domain of Mental and Physical health,Norwegian Institute of Public Health,Oslo,Norway.Correspondence[email protected]

show all

Figures & data

Fig. 1 Inclusion in study based on participants in the Norwegian Mother and child cohort study

Table 1 Drug name and number of prescriptions for all sedative drugs from birth until 18 months of age^a in our selection of children in the MoBa cohort, 3071 children with unique IDs

Download CSV Display Table

Table 2 Agreement between at least one-time mother reported use of hypnotics and at least one dispensed prescription for a hypnotic drug to children aged 0–18 months

Download CSV Display Table

Table 3 Validity of maternal report on use of compared to number of dispensed prescriptions of alimemazine

Download CSV Display Table

Table 4 Sociodemographic characteristics of alimemazine use categorized in three groups: reported use in MoBa but no prescriptions in NorPD, no reported use in MoBa but prescription in NorPD and reported use in MoBa and prescription in NorPD

Download CSV Display Table

Supplemental material

Shows the questions concerning medication use from the Norwegian Mother and Child cohort study questionnaire Q4 (6 months of age) and Q5 (18 months of age). (DOCX 971 kb)

Download MS Word (971.3 KB)

Hypnotics use in children 0–18 months: moderate agreement between mother-reported survey data and prescription registry data

Table 1 Drug name and number of prescriptions for all sedative drugs from birth until 18 months of age^a in our selection of children in the MoBa cohort, 3071 children with unique IDs

Table 2 Agreement between at least one-time mother reported use of hypnotics and at least one dispensed prescription for a hypnotic drug to children aged 0–18 months

Table 3 Validity of maternal report on use of compared to number of dispensed prescriptions of alimemazine

Table 4 Sociodemographic characteristics of alimemazine use categorized in three groups: reported use in MoBa but no prescriptions in NorPD, no reported use in MoBa but prescription in NorPD and reported use in MoBa and prescription in NorPD

Shows the questions concerning medication use from the Norwegian Mother and Child cohort study questionnaire Q4 (6 months of age) and Q5 (18 months of age). (DOCX 971 kb)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Hypnotics use in children 0–18 months: moderate agreement between mother-reported survey data and prescription registry data

Figures & data

Table 1 Drug name and number of prescriptions for all sedative drugs from birth until 18 months of agea in our selection of children in the MoBa cohort, 3071 children with unique IDs

Table 2 Agreement between at least one-time mother reported use of hypnotics and at least one dispensed prescription for a hypnotic drug to children aged 0–18 months

Table 3 Validity of maternal report on use of compared to number of dispensed prescriptions of alimemazine

Table 4 Sociodemographic characteristics of alimemazine use categorized in three groups: reported use in MoBa but no prescriptions in NorPD, no reported use in MoBa but prescription in NorPD and reported use in MoBa and prescription in NorPD

Shows the questions concerning medication use from the Norwegian Mother and Child cohort study questionnaire Q4 (6 months of age) and Q5 (18 months of age). (DOCX 971 kb)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Table 1 Drug name and number of prescriptions for all sedative drugs from birth until 18 months of age^a in our selection of children in the MoBa cohort, 3071 children with unique IDs